Authors | Factors related to psychological problems | Impacts of psychological problems on CBG testing and insulin injection |
---|---|---|
Ong et al. 2014 | Patient's emotion Low support and insufficient knowledge | Misconception toward glucose monitoring and nonadherence to medication taking |
Taylor et al. 2017 | Insufficient knowledge related to SMBG Unclear communication between health-care providers and patients | Misconception related to SMBG, influence of the diabetes-related stigma, and physiological and psychological issues |
Nazmi et al. 2013 | Experience of pain or discomfort while pricking the finger | Patients discouraged from monitoring blood glucose |
Shlomowitz and Feher 2014 | Experience of finger prick anxiety Injection pain | Avoiding self-monitoring by CBG |
Authors | Strategies | Description of the strategy |
---|---|---|
Snoek et al. 2008 | A 5-step psychosocial model of SMBG | Deciding whether or not to perform a test. This choice may be based on routine Deciding whether or not to perform an analysis; this choice is based on the method Behavioral psychology to predict the negative experience with SMBG Diabetes education and sufficient cognitive ability Immediate action of SMBG Appraisal of SMBG outcomes |
Welschen et al. 2013 | Cognitive behavioral therapy (CBT) | The CBT explores the negative beliefs that generate a contrary conclusion, anxiety, depression, and guilt. This strategy involves challenging negative thoughts and has been used to alter behaviors and to treat mood disorders |
Funnell et al. 2004 | Confrontation, persistence, and reality (CPR) strategy | The CPR focuses on confrontation and assessment of patient's obstacles, including psychological issues Persistence is talking about the interaction and collaboration between patients and health-care provider in diabetes care The reality aspect covers the ongoing monitoring process |
Cox et al. 2006 | Blood glucose awareness training (BGAT) | This is a psychoeducational intervention that consists of education on blood glucose and how diabetes management affects blood glucose level Empowering patients with such information and skills is through BGAT Detection of extreme blood glucose, a sequel to excessive blood glucose, and psychological issues such as fear and depressive symptoms |
Sources of data | Keywords |
---|---|
PubMed | * Fear AND Capillary blood glucose OR Insulin injection AND Diabetes |
Scopus | * Fear AND Capillary blood glucose OR Insulin injection AND Diabetes |
CINAHL | * Fear AND Capillary blood glucose OR Insulin injection AND Diabetes |
Google Scholar | * Fear AND Capillary blood glucose OR Insulin injection AND Diabetes |
Authors | Study designs | Psychological issues related to CBG testing and insulin injection |
---|---|---|
Ong et al. 2014 | Qualitative design | Fear of needles and the fingertip pricking being painful Frustration related to high blood glucose reading Lack of motivation of SMBG |
Taylor et al. 2017 | Mixed qualitative and quantitative design | Stress and emotions described as shame, laziness, and forgetfulness among patients, family members, and community members |
Van Dooren et al. 2016 | Cohort study | High levels of depressive and anxiety symptoms related to diabetes management Personality traits including negative affectivity, the tendency to experience negative emotions across situations and during social interaction The tendency to inhibit the expression of feelings in social interactions to avoid disapproval |
Gucciardi et al. 2013 | Qualitative design | Negative emotional responses to unexpected blood glucose readings, burden of SMBG, and lack of self-discipline |
Shlomowitz et al. 2014 | Cross-sectional study | 58% of patients presented finger prick anxiety and 30% of patients had general anxiety |
Yoshioka 2018 | Editorial | Misconception on effectiveness of insulin injection Fear of and pain during injection by needles Fear of their suffering from hypoglycemic/hyperglycemic symptoms Wrong belief on insulin injection as treatment failure |
Bai et al. 2018 | Meta-analysis | Depression on long-term insulin therapy |